An Open-label Study of HS-20137 in Participants With Moderate-to-Severe Plaque Psoriasis

StatusRecruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this study is to evaluate the safety and efficacy of HS-20137 in the treatment of participants with moderate-to-severe plaque psoriasis
Trial Details
NCT Number NCT07879885
Lead Sponsor Hansoh BioMedical R&D Company
Conditions
(from sponsor)		 Moderate-to-severe Plaque Psoriasis
Enrollment 390 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov